Sharaphunkhadi Granules for Sickle cell Anemia

A Pre-clinical study and Pilot clinical study on Sharapunkhadi Granules in childhood sickle cell anemia - SG - SCA

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/12/038971

Enrollment

Registered

2021-12-28

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D758- Other specified diseases of bloodand blood-forming organs

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Pre diagnosed cases will be taken only. Age between 3 years to 16 years irrespective of gender caste religion Patients with sign and symptoms of sickle cell anaemia Hb >6.5 gm% and Hb electrophoresis reporting % of Hb S >10 gm% Serum Bilirubin less than 3.0 mg/dL

Exclusion criteria

Exclusion criteria: Age less than 3 years and greater than 16 years Patients with known case of Hepatic, Renal Dysfunction Chronic Cardiac Dysfunction SCA associated with other known diseases like Diabetes Mellitus Hypertension Hb 11.5 gm%. Serum bilirubin level more than 3.0mg/dL Known case of other Haemoglobinopathies and Haematological diseases other than Sickle cell anaemia G6PD Thalassemia Sickle cell beta thalassemia

Design outcomes

Primary

Measure	Time frame
Improvement in Hb and hematological indices and quality of life of sickle cell childrenTimepoint: o day 2 weeks 4 weeks 6 weeks and 8 weeks	—

Secondary

Measure	Time frame
Improvement in Quality of Life of children with Sickle Cell AnemiaTimepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Pinakumai Patel

Parul Institute of Ayurved

neonatecare99@gmail.com

Outcome results